Regenxbio climbs as new director buys nearly $1 million of stock
BUZZ-Regenxbio climbs as new director buys nearly $1 million of stock ** Shares of drug developer Regenxbio RGNX.O rise 9.4% to $10.25 premarket
** RGNX on Tuesday appointed Gregory Ciongoli to its board of directors as two long-serving directors retired
** Ciongoli receives an initial equity award of 15,432 restricted stock units and stock options to buy 69,609 shares
** Ciongoli buys 102,603 RGNX shares over two days at weighted-average prices of $9.14 and $9.36, worth about $952,001.59 in total, filings made public late on Thursday show
** These acquisitions increase his total holding in the company to 118,035 shares
** On Monday, Regenxbio said that the FDA had placed its experimental Hunter syndrome gene therapy on clinical hold, sending its shares down nearly 25%
** As of last close, stock down 34.9% YTD
(Reporting by Kamal Choudhury in Bengaluru)
Recent news on REGENXBIO
See all newsBrief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics